Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer.
about
CixutumumabSynergistic Effects of Chinese Herbal Medicine: A Comprehensive Review of Methodology and Current ResearchDual small-molecule targeting of procaspase-3 dramatically enhances zymogen activation and anticancer activityCombination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirusMechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian CancerSolid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil.Solid tumor models for the assessment of different treatment modalities: systematics of response to radiotherapy and chemotherapy.Quantity and accessibility for specific targeting of receptors in tumours.Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy.Multi-layered nanoparticles for combination gene and drug delivery to tumors.Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patientsCancer chemotherapy: new strategies for success.A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cellsChemotherapy of advanced neuroblastoma: does adriamycin contribute?Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cellsSynergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid.Non-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapyMacrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction.Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatmentIn vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.Combined treatment of a solid tumour by local hyperthermia and actionomycin D.Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer.Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell linesIs it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapyPrediction of multidimensional drug dose responses based on measurements of drug pairs.ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.Cancer prevention and treatment using combination therapy with plant- and animal-derived compounds.DNA nanostructure-based imaging probes and drug carriers.Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.An application of a Hill-based response surface model for a drug combination experiment on lung cancer.Multifunctional theranostic red blood cells for magnetic-field-enhanced in vivo combination therapy of cancer.Predictive approaches for drug combination discovery in cancer.The current role of cancer chemotherapy.Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo.Marrow relapse on maintenance chemotherapy in childhood acute lymphoblastic leukaemia.Chemotherapy of metastatic carcinoma of the breast. A 4-drug regimen.Is there an alternative to alternating adjuvant therapy for breast cancer?Kinetic concepts in the treatment of breast cancer.
P2860
Q24609058-18F99E77-0E5D-41B2-8947-0043ABD51112Q26741422-A8EBF273-7697-4C40-885D-5406FE726D3AQ28304985-625DC3EF-1151-4F8A-A089-339EC31E8481Q28366028-02D87258-9515-439E-950F-EC8BF929C234Q28366289-F3001282-B4A9-4789-A920-A289FE215E90Q29247912-3254B71C-DFC2-4789-B9DB-76D4D530DCA5Q30438674-854ABFA6-959C-4D02-8432-104554ACB4A1Q30449129-29DE537C-E815-4FE7-AC72-FCA5C91514A8Q30580276-FC886D14-143D-483B-8B1B-77E4D403D769Q33668647-7E0A6B75-CE3D-4B26-9370-38B9630FA26DQ34135640-5EB7E5CE-957D-437C-9D89-5E3743D704FBQ34417986-7E14964E-8C4D-4C99-9C1C-78A0E758E7A7Q34545133-91111AC0-DA9D-4532-934B-B5A831542BCCQ34948354-D878871B-E35E-4AF4-80B3-3DAE7927E70FQ35115333-97FEAF76-ED53-40B9-B00D-1528E3DD3AECQ35678181-6674E632-37FF-4F1D-BDA5-4B66108A1BD0Q35751958-6F810559-56D6-4E4A-8F1E-345D71BAA2C4Q35777355-EBF0D0DD-1410-4E14-AA9B-C2EEC99936C8Q35846594-99A11E4E-9F80-4FF5-A31A-D7D17DFA79E1Q35979751-ADF2DE20-0C9C-4F8C-BA93-103A1E4BFCE5Q35992368-B4EB5003-87F1-432C-B29A-BE83634167B0Q36042139-D5C1C5F8-C3ED-4DBE-8622-D2760A8D66F4Q36219217-80B34A91-B591-425D-93E5-B37E9CB2C036Q36680180-A5F1EDC6-73D3-442C-9C4A-6B69E6D644E3Q36880024-9AE1AEAD-5766-4447-8D6D-DAA20E77AF6CQ36952188-EEB1BF55-3ADB-41D2-B82A-35E38274C677Q37264069-9E919A05-E989-41F4-84B2-6255A7C99A56Q37712188-A065ABDF-835C-4EDF-98D3-C9BB232994EFQ38066962-A499060A-0C6A-408B-99C9-1CEB55AEEB56Q38232047-B944A198-B916-40CC-BD61-365D04180D2BQ38860787-4C499DCB-E0F4-4325-8906-6AEF1BDEAACCQ38983370-7EF6A99D-FB2A-4EE4-82E8-9F3ACF1596BCQ38994042-DCFA2B48-DB46-41A8-9D52-7CA391510546Q39018410-D40DFE93-27D6-4EEA-94F2-DFC1D6D3260AQ39776420-A3EB6B17-15D9-475C-8DF8-FF5CE4FCE5DFQ40134887-75842AA5-3F75-431F-B734-BE704290E69DQ40632775-E25F1EE4-26E1-42A6-B11F-C887726F3812Q40648804-933F5CDF-2CC1-412B-948B-546CC941038EQ40754410-AEF2BED3-0571-47F2-917C-60D74BF0768AQ40800336-DB74C329-BB1A-435C-A4DB-55BA24688E28
P2860
Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Combination versus single agen ...... n of drug treatment of cancer.
@ast
Combination versus single agen ...... n of drug treatment of cancer.
@en
type
label
Combination versus single agen ...... n of drug treatment of cancer.
@ast
Combination versus single agen ...... n of drug treatment of cancer.
@en
prefLabel
Combination versus single agen ...... n of drug treatment of cancer.
@ast
Combination versus single agen ...... n of drug treatment of cancer.
@en
P2093
P1433
P1476
Combination versus single agen ...... n of drug treatment of cancer.
@en
P2093
Canellos GP
DeVita VT Jr
P304
P356
10.1002/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO;2-B
P407
P577
1975-01-01T00:00:00Z